These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15578948)

  • 1. Ribozyme- and deoxyribozyme-strategies for medical applications.
    Schubert S; Kurreck J
    Curr Drug Targets; 2004 Nov; 5(8):667-81. PubMed ID: 15578948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribozymes in the age of molecular therapeutics.
    Bagheri S; Kashani-Sabet M
    Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic DNA: a novel tool for gene suppression.
    Cairns MJ; Saravolac EG; Sun LQ
    Curr Drug Targets; 2002 Jun; 3(3):269-79. PubMed ID: 12041740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribozyme: a clinical tool.
    Khan AU
    Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro.
    Ohkawa K; Yuki N; Kanazawa Y; Ueda K; Mita E; Sasaki Y; Kasahara A; Hayashi N
    J Hepatol; 1997 Jul; 27(1):78-84. PubMed ID: 9252077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient inhibition of hepatitis B virus replication by hammerhead ribozymes delivered by hepatitis delta virus.
    Li X; Kuang E; Dai W; Zhou B; Yang F
    Virus Res; 2005 Dec; 114(1-2):126-32. PubMed ID: 16054262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of ribozymes for gene therapy.
    Sullivan SM
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):85S-89S. PubMed ID: 7963690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent.
    Branch AD; Robertson HD
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10163-7. PubMed ID: 1946436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozymes as antiviral agents.
    Bartolomé J; Castillo I; Carreño V
    Minerva Med; 2004 Feb; 95(1):11-24. PubMed ID: 15041923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
    Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases.
    Grassi G; Dawson P; Guarnieri G; Kandolf R; Grassi M
    Curr Pharm Biotechnol; 2004 Aug; 5(4):369-86. PubMed ID: 15320768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and mode of action of hammerhead and hairpin ribozymes against various HIV-1 target sites.
    Hotchkiss G; Maijgren-Steffensson C; Ahrlund-Richter L
    Mol Ther; 2004 Jul; 10(1):172-80. PubMed ID: 15233952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribozyme relationships: the hammerhead, hepatitis delta, and hairpin ribozymes have a common origin.
    Harris RJ; Elder D
    J Mol Evol; 2000 Aug; 51(2):182-4. PubMed ID: 10948275
    [No Abstract]   [Full Text] [Related]  

  • 17. Catalytic cleavage of cis- and trans-acting antigenomic delta ribozymes in the presence of various divalent metal ions.
    Wrzesinski J; Legiewicz M; Smólska B; Ciesiolka J
    Nucleic Acids Res; 2001 Nov; 29(21):4482-92. PubMed ID: 11691936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribozyme mediated destruction of influenza A virus in vitro and in vivo.
    Tang XB; Hobom G; Luo D
    J Med Virol; 1994 Apr; 42(4):385-95. PubMed ID: 8046429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modern mode of activation for nucleic acid enzymes.
    Lévesque D; Brière FP; Perreault JP
    PLoS One; 2007 Jul; 2(7):e673. PubMed ID: 17653287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.